ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 65 filers reported holding ENZO BIOCHEM INC in Q3 2021. The put-call ratio across all filers is 3.06 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 1 | -100.0% | 0.00% | -100.0% |
| Q1 2018 | $137,000 | -86.3% | 24,942 | -79.6% | 0.00% | -87.0% |
| Q4 2017 | $997,000 | -27.6% | 122,334 | -7.0% | 0.02% | -28.1% |
| Q3 2017 | $1,377,000 | +44.3% | 131,493 | +52.2% | 0.03% | +45.5% |
| Q2 2017 | $954,000 | -4.8% | 86,402 | -27.8% | 0.02% | -8.3% |
| Q1 2017 | $1,002,000 | +11.0% | 119,681 | -8.1% | 0.02% | +14.3% |
| Q4 2016 | $903,000 | +21.4% | 130,159 | -11.0% | 0.02% | +23.5% |
| Q3 2016 | $744,000 | +26.3% | 146,235 | +48.3% | 0.02% | +13.3% |
| Q2 2016 | $589,000 | – | 98,621 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evermore Global Advisors, LLC | 3,555,233 | $39,250,000 | 9.97% |
| CORRADO ADVISORS, LLC | 326,101 | $3,600,000 | 1.97% |
| KOPP INVESTMENT ADVISORS LLC | 199,132 | $2,198,000 | 1.97% |
| First Light Asset Management, LLC | 403,082 | $4,450,000 | 1.49% |
| Millrace Asset Group, Inc. | 115,878 | $1,279,000 | 1.21% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $1,054,000 | 0.69% |
| MARATHON CAPITAL MANAGEMENT | 115,000 | $1,270,000 | 0.60% |
| Campbell & CO Investment Adviser LLC | 33,513 | $370,000 | 0.34% |
| EAM Investors, LLC | 159,930 | $1,766,000 | 0.29% |
| ABNER HERRMAN & BROCK LLC | 100,000 | $1,104,000 | 0.21% |